Cost-effectiveness analysis comparing robotic sacrocolpopexy to a vaginal mesh hysteropexy for treatment of uterovaginal prolapse
Reads0
Chats0
TLDR
Vaginal mesh was more cost-effective than robotic sacrocolpopexy even when the cost of the robot was not factored.Abstract:
Objective: To compare costs and QoL associated with 2 minimally invasive operations to treat uterovaginal prolapse. Study Design: A decision analytic cost-effectiveness model comparing vaginal mesh hysteropexy to robotic-assisted sacrocolpopexy. Costs were derived from a hospital perspective. QoL estimates focused on: recurrent prolapse; erosion; infection; transfusion; cystotomy; chronic pain; lower urinary tract symptoms; and mortality. Actual procedural costs at our institution were calculated. Costs and quality adjusted life years were examined over 1 year. Results: The costs ($21,853) and QALYs (0.9645) for robotic sacrocolpopexy produced a CE Ratio of $22,657 per QALY. The costs ($14,890) and QALYs (0.9309) for vaginal mesh produced a CE Ratio of $15,995 per QALY. The incremental cost per QALYs for robotic surgery was $207,232. Sensitivity analysis on all utilities, cost estimates, and complication estimates didn’t cross any thresholds. Conclusion: Vaginal mesh was more cost-effective than robotic sacrocolpopexy even when the cost of the robot was not factored.read more
Citations
More filters
Journal ArticleDOI
Preoperative and postoperative analysis of site‐specific pelvic support defects in 81 women treated with sacrospinous ligament suspension and pelvic reconstruction
TL;DR: Absence of any pelvic support defect at the 6-week postoperative visit is associated with a 3% likelihood that the patient will require subsequent reconstructive surgery within 2 to 5 years.
Journal ArticleDOI
Nonoperative management of adhesive small bowel obstruction: what is the break point?
Alexander L. Colonna,Nickolas Byrge,Scott D. Nelson,Richard E. Nelson,Michael Hunter,Raminder Nirula +5 more
TL;DR: Surgery after the first episode of SBO provides a small increase in QALY at a small cost since surgical intervention lowers the risk of recurrence.
Journal ArticleDOI
Abdominal sacral colpopexy versus sacrospinous ligament fixation: a cost-effectiveness analysis
TL;DR: Abdominal sacral colpopexy can be cost- effective compared with sacrospinous ligament fixation; however, as the post-operative outcomes of SSLF improve, SSLF can be considered a cost-effective alternative.
References
More filters
Journal ArticleDOI
Abdominal sacrocolpopexy: a comprehensive review.
Ingrid Nygaard,Rebecca McCreery,Linda Brubaker,AnnaMarie Connolly,Geoff Cundiff,Anne M. Weber,Halina M. Zyczynski +6 more
TL;DR: Sacrocolpopexy is a reliable procedure that effectively and consistently resolves vaginal vault prolapse and patients should be counseled about the low, but present risk, of reoperation for prolapse, stress incontinence, and complications.
Journal ArticleDOI
Sacrospinous ligament fixation for eversion of the vagina
TL;DR: The surgical goals described were attained and use of the sacrospinous ligament fixation procedure as a therapeutic procedure only is defended.
Journal ArticleDOI
Short-term outcomes of robotic sacrocolpopexy compared with abdominal sacrocolpopexy.
TL;DR: Robotic sacrocolpopexy demonstrated similar short-term vaginal vault support compared with abdominal sacro colopexy, with longer operative time, less blood loss, and shorter length of stay, and long-term data are needed to assess the durability of this new minimally invasive procedure.
Journal ArticleDOI
Ovarian Conservation at the Time of Hysterectomy for Benign Disease
William H. Parker,Michael S. Broder,Zhimei Liu,Donna Shoupe,Cindy Farquhar,Jonathan S. Berek +5 more
TL;DR: Ovarian conservation until at least age 65 benefits long-term survival for women at average risk of ovarian cancer when undergoing hysterectomy for benign disease.
Journal ArticleDOI
Trocar-guided mesh compared with conventional vaginal repair in recurrent prolapse: a randomized controlled trial.
TL;DR: The number of anatomic failures observed after tension-free vaginal mesh insertion was less than after conventional vaginal prolapse repair at 12 months, and symptom decrease and improvement of quality of life were equal in both groups.